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Abstract: Gynostemma pentaphyllum (var. Ginpent) (GP) is a variety of Cucurbit with anti-inflammatory
and antioxidant effects in patients. In this manuscript, the main components present in the dry extract
of GP have been identified using Ultra High Performance Liquid Chromatography quadrupole-time-
of-flight mass spectrometry (UHPLC/Q-TOF-MS). In addition, the anti-inflammatory action of GP
was evaluated in animal models with acute peripheral inflammation and motor alteration induced
by lipopolysaccharide. The results showed that GP dry extract is rich in secondary metabolites
with potential antioxidant and anti-inflammatory properties. We found that the treatment with GP
induced a recovery of motor function measured with the rotarod test and pole test, and a reduction in
inflammatory cytokines such as interleukin-1β and interleukin-6 measured with the ELISA test. The
data collected in this study on the effects of GP in in vivo models may help integrate the therapeutic
strategies of inflammatory-based disorders.
Keywords: Gynostemma pentaphyllum; supplement; anti-inflammatory; motility; ELISA
1. Introduction
1.1. The Plant phytocomplex
Plants produce secondary metabolites in the leaves, stem or roots, with allelopathic,
defensive or attractive functions towards other plants or animals [1–3]. Over the past
70 years, single secondary metabolites have been isolated, purified, and synthesized
ex-novo and their biological activity has been evaluated [4–7]. Important therapeutic
applications have been found for many of these molecules, but in other cases, clear and
definitive results have not been obtained [8,9]. In recent decades, studies on the biological
activity of phytocomplexes have been growing. The characterization of the phytocomplex
does not focus on a single compound produced by the plant, but on the heterogeneous set
of different molecules present in a specific area of the plant at a particular time of vegetative
life [10,11]. This new approach allows the evaluation of many ecological parameters
such as soil nutrients, abiotic and biotic stress, and the presence of other plants. These
parameters affect the quantity and quality of the secondary metabolites present in the
plant and consequently their biological activity [12–14]. Indeed, the ethnopharmacological
properties of a phytocomplex do not always coincide with the biological effects observed
for each single molecule present in it [15–17]. Starting from these considerations, the
anti-inflammatory properties of the phytocomplex of a variety of Gynostemma pentaphyllum
(var. Ginpent) (GP) have been studied.
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1.2. Overview on Gynostemma pentaphyllum
GP belongs to the Cucurbitaceae, it is a perennial plant with a lianose habit, and it
grows spontaneously in Indochina [18,19]. The studies present in the scientific literature
exclusively concern the variety Gynostemma pentaphyllum (Thunb.) Makino (GTM) in sev-
eral models [20–23]. Furthermore, the uses of GTM in traditional medicine are diverse,
including the treatment of bronchitis, asthma, liver disorders, fat tissue disorders, and
inflammatory and oncological pathologies [21,23–25]. GTM could reduce inflammatory
heart damage by inhibiting the activation of NF-κB p65 via the mitogen-activated protein
kinase (MAPK) signalling pathway in the H9c2 cell model [26]. Furthermore, it has been
reported that GTM extracts are involved in the inhibition of inflammatory signalling me-
diated by IL-6, IL-1β, COX-2, TNF-α and NO in RAW264.7 macrophage cells stimulated
with lipopolysaccharide (LPS) [20]. Finally, GTM could inhibit the activation of the proin-
flammatory signalling pathways NF-κB and STAT3 and the production of proinflammatory
cytokines in intestinal inflammation models [23]. Although the anti-inflammatory action
of GTM has been defined in different in vitro and in vivo studies, no model explores the
effects related to motor behaviour. Furthermore, in vivo experimental results on the action
of GP have not yet been performed.
In this work, the anti-inflammatory and motor coordination effects of a supplement
based on GP were evaluated in mice treated with lipopolysaccharide (LPS). In vivo acute
treatment with lipopolysaccharide is a standard method to induce inflammation, with
the release of inflammatory cytokines and the alteration of some physiological functions,
such as motor activity [27]. GP, a formulation already on the market as a food supplement
(GinPent®, Leno, Italy) with potential adaptogenic, antidiabetic and lipid-lowering activ-
ities, was used for preventive purposes three days before the inflammatory stimulation.
Furthermore, the effects of GP on motor coordination were evaluated with the pole and the
rotarod test while the anti-inflammatory action was evaluated with the enzyme-linked im-
munosorbent assay (ELISA) test. Finally, the identification of some secondary metabolites
present in the GP extract was performed.
2. Materials and Methods
2.1. Plant Material
GP is derived from a selected variety of the Gynostemma pentaphyllum (var. Ginpent)
(Plant Reg. 8488) owned by AMBRAFARM srl, Leno, Italy (Figure 1). The whole plant
of GP was collected from Leno (45◦21′52.3” N 10◦11′53.9” E), Province of Brescia, Italy,
in October 2019. The leaves of GP were dried, chopped and pulverized before the mice
treatment and the analytical procedures. One sample of GP was kept at the Department of
Molecular and Translational Medicine, Division of Pharmacology, University of Brescia.
2.2. UHPLC-QTOF Analysis of Bioactive Compounds
In this work, triplicate specimens of the test sample were analysed by Ultra High Per-
formance Liquid Chromatography quadrupole-time-of-flight mass spectrometry (UHPLC-
ESI/QTOF-MS). To this aim, samples were extracted through Ultra-Turrax (VWR, Milano,
Italy) as previously reported [28]. Thereafter, a 34 min linear elution gradient using a binary
mixture of acetonitrile in water (from 5 to 94%, flow 220 µL/min, T = 35 ◦C) and a Zorbax
Eclipse-plus column (75× 2.1 mm i.d., 1.8 µm-Agilent Technologies, Santa Clara, CA, USA)
were used for chromatographic separation [29]. The mass spectrometer was operated in
full-scan mode and positive polarity, acquiring in the range 100–1200 m/z [28].
Raw data underwent mass and retention time alignment and were then deconvoluted
in Agilent Profinder B.06 (Agilent, Santa Clara, CA, USA). Features were finally annotated
according to a level 2 of confidence in annotation [30] against two databases, namely Phenol-
Explorer 3.6 [31] and a custom database prepared from known saponins and phytosterols
reported in literature.
Molecules 2021, 26, 570 3 of 14




Figure 1. Crops of Gynostemma pentaphyllum (var. Ginpent) from Leno, Brescia, Italy. 
2.2. UHPLC-QTOF Analysis of Bioactive Compounds 
In this work, triplicate specimens of the test sample were analysed by Ultra High 
Performance Liquid Chromatography quadrupole-time-of-flight mass spectrometry 
(UHPLC-ESI/QTOF-MS). To this aim, samples were extracted through Ultra-Turrax 
(VWR, Milano, Italy) as previously reported [28]. Thereafter, a 34 min linear elution 
gradient using a binary mixture of acetonitrile in water (from 5 to 94%, flow 220 µL/min, 
T = 35 °C) and a Zorbax Eclipse-plus column (75 × 2.1 mm i.d., 1.8 µm-Agilent 
Technologies, Santa Clara, CA, USA) were used for chromatographic separation [29]. The 
mass spectrometer was operated in full-scan mode and positive polarity, acquiring in the 
range 100–1200 m/z [28]. 
Raw data underwent mass and retention time alignment and were then 
deconvoluted in Agilent Profinder B.06 (Agilent, Santa Clara, CA, USA). Features were 
finally annotated according to a level 2 of confidence in annotation [30] against two 
databases, namely Phenol-Explorer 3.6 [31] and a custom database prepared from known 
saponins and phytosterols reported in literature. 
Phenolic compounds were finally classified in classes according to Phenol-Explorer 
3.6 annotations, and cumulate compound abundance from each class was quantified 
using calibration curves built from pure reference standards [32]. In more detail, catechin 
was used for flavanols, cyanidin for anthocyanins, luteolin for flavones and other 
remaining flavonoids, sesamin was used for lignans, ferulic acid for hydroxycinnamic 
acids and other phenolic acids, resveratrol for stilbenes, 5-pentadecylresorcinol 
alkylphenols, and tyrosol was used for tyrosols and other low molecular weight 
i re 1. Crops of Gynostemma entaphyllum (var. Ginpent) from Leno, Brescia, Italy.
Phenolic compounds were finally cla sified in classes according to Phenol-Explorer
3.6 annotations, and umulate compound abundance from each class w s quantified using
calib ation curves built from pure reference standards [32]. In more detail, catechin was
used for flavanols, cyanidin for anthocyanins, luteolin for flavones and other remaining
flavonoids, sesamin was used for lignans, ferulic acid for hydroxycinnamic acids and other
phenolic acids, resveratrol for stilbenes, 5-pentadecylresorcinol alkylphenols, and tyrosol
was used for tyrosols and other low molecular weight phenolics. Regarding saponins and
phytosterols compound classes, they were qu tified using Ginsenoside-Rb and cholesterol
(Sigma-Aldrich, Milan, Italy) standard curves, respectively.
2.3. Animals a d Treatment
All experiments were performed according to the European Union guidelines (CEE
N◦86/609) for the care and use of experimental animals and approved by the Italian
Ministry of Health (381/2019-PR), Animal Care and Use Committee of the University
of Bresci .
Forty male mice (2–3 months old, 25–30 g, B6;129PF2) fed a standard diet, and housed
in 4-individuals/cage at controlled temperature and humidity, were used. Animals were
fed ad libitum with a normal chow (D12450B, 10% fat, 70% carbohydrate, 20% protein, total
3.85 kcal/g; Research Diets Inc., New Brunswick). We randomly divided the animals into
two groups balanced on body weight, with 20 mice per group. The groups were: control
group treated with vehicle (VH, for three days, saline solution), group treated with GP (GP,
for three days). The GP solution was prepared fresh every morning, starting from a pool
of 10 capsules. The desired quantity was weighed, solubilized in physiological solution
(NaCl 0.9%), sonicated, and administered by oral gavage (20 mg/kg).
On the third day, ten GP and ten VH mice received the inflammatory stimulus
(lipopolysaccharide, LPS, L-3129 serotype 0127:B8, MilliporeSigma, Merck KGaA, Darm-
stadt, Germany). LPS was administered intraperitoneally (i.p.) at a dosage of 7.5 mg/kg.
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The dosage was chosen on the basis of data previously reported in the literature [33]. The
remaining 10 GP animals and 10 VH animals received i.p. saline (Figure 2).
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After about 6 h from the a ministration of the LPS, the animals were subjected to
motor tests: “Pole Test” and “Rotarod test”.
2.4. Behavioural Test: Pole Test and Rotarod Test
The pole test was performed following a modified protocol previously described [34].
In particular, a 0.5 m long pole was placed vertically in the home cage and the ice were
placed high. The time required to re-descend into the cage was recorded. The mice were
trained on the pole test for two consecutive days. Each mouse received three consecutive
training trials, each separated by 30 min rest periods. On the third day, the mice were
tested and the average time to return to the cage was recorded. Furthermore, a score value
was calculated based on the performance of the mouse, as previously reported [27].
The acceleration rotarod test was conducted as previously described [5]. Briefly,
the mice were placed on the rotarod (Ugo Basile, Varese, Italy) in acceleration, which
accelerated from 2 to 20 rpm in 300 s and the latency at the fall was recorded. The time
each rodent managed to stay on top of the rotarod was recorded.
2.5. ELISA Test
At the end of motility tests, mice were euthanized by cervical dislocation and the
blood was processed to quantify the cytokines. Approximately 500 µL of blood from each
animal was centrifuged at 1000× g for 10 min, and the serum was used for enzyme-linked
immunosorbent assay (ELISA) determination of interleukin 1β (IL-1β), interleukin 6 (IL-6)
and interleukin 10 (IL-10). These serum samples were tested with ELISA KIT (Thermo
Fisher, Monza, Italy) following the manufacturer’s protocol.
2.6. Statistical Analysis
All data are expressed as mean ± standard error of the mean (S.E.M.) and analysed
by ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test for the
comparison of individual means. All the statistical analysis was obtained by using the
GraphPad Prism version 6.01 (GraphPad Software, San Diego, CA, USA).
3. Results and Discussion
3.1. Chemical Components in GP Extracts
From the analysis by UHPLC/Q-TOF-MS of the dry extract of GP, secondary metabo-
lites with several potential therapeutic applications have been identified. The most repre-
sentative molecules were selected and discussed below. GP could have adaptogenic, anti-
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inflammatory, antidiabetic, lipid-lowering and anti-arthritic effects in patients [21,24,25].
Many of these functions have been associated with the molecules identified in this work.
3.1.1. Saponins
Saponins are glycosides with functional groups of triterpenoids or spirostanols [35].
They are mainly synthesized in higher terrestrial plants and in a few marine organisms.
Like all secondary metabolites produced by plants, the saponin content is also influenced
by various biotic stimuli such as parasite attacks, pathogenic infections, the mutualistic
symbiosis of plants with rhizobium bacteria and mycorrhizal fungi [35]. Saponins are
functional components of many plant-based drugs and popular medicines and have shown
an important function in improving the inflammatory, immune and anticancer response
and in reducing cholesterol [36,37]. Furthermore, saponins showed good activity in cel-
lular protection from ischemia and hypoxia [38]. Based on their structure, saponins are
mainly classified into two classes: triterpene saponins and steroid saponins. The saponins
identified in the GP samples are of the triterpene type (Table 1). Ginsenosides are the main
saponins identified in our GP samples, reaching a total of 7.2 mg/L (as azadirachtin B
equivalent). Ginsenosides are predominantly present in Areliaceae such as in Panax ginseng,
and Gynostemma pentaphyllum is the only plant not belonging to the Araliaceae that contains
ginsenosides [39]. Natural ginsenosides must first be transformed into secondary saponins
by the metabolism of the gastrointestinal flora before being absorbed, as observed by He
and colleagues [35]. Their main clinical applications concern pathologies with an inflamma-
tory basis, cardiovascular diseases, diabetes and gastrointestinal diseases [40]. The specific
triterpene saponin of Gynostemma pentaphyllum is gypenoside. Interestingly, we detected
both gypenoside XXV and gypenoside XLVI in the GP extracts. Indeed, gypenoside has
shown anti-aging, anticancer, hypoglycaemic, lipid-lowering and neuroprotective effects,
as reported by some authors [22,41–43]. In addition, the environment can influence the
synthesis and accumulation of gypenosides. For instance, some fungi present in the soil
can stimulate or inhibit the synthesis of gypenosides [39].
Table 1. Semi-quantification of selected saponins (as mg/L Equivalent) detected in Gynostemma
pentaphyllum (var. Ginpent) extracts.
Name Formula mg/L ± SD (as Ginsenoside-Rb eq.)
Ginsenoside
“RF1”/“RF2”/“RF2-2” C42 H72 O13 4.67 ± 0.23
Protopanaxatriols C30 H52 O4 1.66 ± 0.10
Ginsenoside RH2 C36 H62 O8 1.44 ± 0.05
Protopanaxadiols C30 H52 O3 1.27 ± 0.02
Ginsenoside RD C48 H82 O18 1.07 ± 0.02
Gypenoside XXV C47 H78 O18 1.06 ± 0.02
Ginsenoside RF C42 H72 O14 0.68 ± 0.01
Isofucosterolo C29 H48 O 0.52 ± 0.01
Ginsenoside RB1 C52 H92 O23 0.36 ± 0.02
Gypenoside XLVI C48 H82 O19 0.31 ± 0.05
Phyllodulcin C16 H14 O5 0.09 ± 0.01
Data are presented as mean values ± standard deviation of three independent replicates.
3.1.2. Polyphenols
To date, nearly 10.000 molecules belonging to the polyphenols class have been iden-
tified among the secondary metabolites produced by plants. Apart from the structural
functions that phenolic derivatives perform in plants such as lignin, polyphenols are an-
tioxidant molecules with a protective function of photosynthetic systems against excessive
radiation. Moreover, they can attract animals to the flowers and fruits of plants [1,2]. In
recent decades, polyphenolic compounds have attracted great attention from a pharma-
ceutical point of view for their antioxidant and anti-inflammatory properties. They have
beneficial effects on health, both in animal models and in clinical trials [44–47]. Figure 3
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shows the main classes of polyphenols identified in GP extracts. The class of low molecular
weight (LMW) polyphenols was the most abundant (i.e., 956 mg/L eq.), followed by other
flavonoids (such as flavonols, flavones, flavanones, and chalcones group), lignans, and
phenolic acids (507, 418 and 211 mg/L eq., respectively). The polyphenols identified in our
GP samples have shown the ability to modulate LPS-mediated inflammation, as reported
by several authors [5,10,48]. Cyanidins, peonidins or malvidins and other derivatives
have been identified and included in the group anthocyanins, also with O-glucosides
modification that is important for the stability and activity of these compounds [49]. An-
thocyanins are important for the determination of colours in plants and show remarkable
antioxidant properties [48,50]. In addition, anthocyanins prevent the action of reactive
oxygen species (ROS) generated by the administration of LPS, as observed by some au-
thors [48,51]. Another polyphenol identified and worthy of interest is ferulaldehyde, a
hydroxycinnamaldehyde found to be able to reduce the inflammatory response by re-
ducing the release of cytokines, such as interleukin-1β and TNF-α, and by inhibiting the
LPS-induced activation of the nuclear factor kappaB pathway in mice models [52]. Inter-
estingly, some authors reported a synergistic effect of ferulaldehyde with Methotrexate
in the therapy of inflammatory arthritis [52]. Among other molecules, sinapine is one of
the most representative phenolic acids in our samples, followed by m-coumaric acid and
2-hydroxybenzoic acid. These compounds have been detected mainly in the methanolic
GP extracts and these chemical structures exert strong antioxidant properties [53]. Indeed,
sinapine can counter reactive oxygen species (ROS) by interacting with mitochondrial
systems, as observed by several authors in cardiomyocyte cultures [54]. Interesting data
have been collected on cirsimaritin, a dimethoxy flavone present in some plants. This
molecule exhibits potent antimicrobial, antioxidant, and antispasmodic activities and also
inhibits cyclooxygenase-1 (COX-1) [55]. Furthermore, it appears to block inflammatory ac-
tion by inhibiting the expression of interleukin-6 (IL-6) and the activity of tumour necrosis
factor-α (TNF-α) in cultures of LPS-stimulated macrophages [56]. Inhibitory actions of the
inflammatory process were also observed in animal models treated with dihydroquercetin,
isorhamnetin and anethole [57].
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3.1.3. Phytosterols
Table 2 shows the main phytosterols identified in our GP samples. Penasterol (4,4-
dimethyl-14-carboxy-cholesta-9(10),24-dien-3beta-ol) has been shown to be the most abun-
dant sterol detected in our extracts (as 178.19 mg/L Eq.). This last sterol was first isolated
from Okinawan marine sponge Penares sp. and was reported to have potent antileukemic ac-
tivity [58]. Phytosterols are plant sterols located in the cell membrane. Moreover, sitosterol-
β-glucoside (3-O-(6′-O-(7Z,10Z-hexadecadienoyl)-beta-D-glucopyranosyl)-stigmast-5-en-
3beta-ol) was found to be involved as a primer for cellulose synthesis in plants by the
action of glucosyltransferase [59]. Phytosterols are also employed in many food sup-
plements used as adjuvants in lipid-lowering therapies; however, some data have also
been collected in the inflammatory context. Phytosterols exert a significant topical anti-
inflammatory activity in animal models, modulate the T-helper immune response in vivo,
and show marked endothelial anti-inflammatory activity [60]. The anti-inflammatory
action results in a reduction in the expression of inflammatory cytokines and the synthe-
sis of anti-inflammatory ones [60]. Plant sterol consumption was also regulated by the
European Food Safety Agency for health claims. Indeed, it was suggested that 3 g/day
plant sterols/stanols can reduce blood LDL-cholesterol and the risk of heart diseases. Fur-
thermore, interesting data have been observed regarding rheumatic pathologies. Indeed,
phytosterols have an anti-stiffness action in the therapy of rheumatic diseases in mouse
models [61]. Additionally, paw oedema and neutrophils infiltration into inflamed tissues in
animal models of induced arthritis are reduced after the administration of phytosterols [61].
On the other hand, in humans it was observed that professional runners who consumed
phytosterols showed a reduced production of IL-6 and other inflammatory parameters [60].
The action of phytosterols at the arthritic level is linked to the penetration of phytosterols
into the cell membranes of the chondrocytes of the cartilage tissue, where they perform
an anti-inflammatory action.
Table 2. Semi-quantification of selected phytosterols (as mg/L equivalent) detected in Gynostemma pentaphyllum (var.
Ginpent) extracts.
Name Formula mg/L ± SD(as cholesterol eq.)
4,4-dimethyl-14-carboxy-cholesta-9(10),24-dien-3beta-ol C30 H48 O3 178.19 ± 14.04
3-O-(6′-O-(7Z,10Z-hexadecadienoyl)-beta-D-
glucopyranosyl)-stigmast-5-en-3beta-ol C51 H86 O7 62.35 ± 2.08
(22R)-22-hydroxystigmast-4-en-3-one C29 H48 O2 53.60 ± 7.39
(22S)-1alpha-acetoxy-5alpha-furospirostan-
3alpha,11beta,20R-triol C30 H48 O7 36.04 ± 2.11
3beta-hydroxy-4alpha-methyl-5alpha-cholest-7-ene-4beta-
carboxylic acid C29 H48 O3 32.70 ± 6.02
4-methylene-5alpha-poriferast-8(14)-en-
3beta,7alpha,15beta-triol C30 H50 O3 30.20 ± 0.95
3beta-acetoxy-cholest-5-en-7-one C29 H46 O3 29.17 ± 5.98
4-methylene-5alpha-poriferast-8(9)-en-
3beta,11beta,14alpha,15alpha-tetrol C30 H50 O4 26.13 ± 1.02
24-isopropenyl-cholesta-5,22E-dien-3beta-ol C30 H48 O 24.38 ± 4.66
Other phytosterols 857.00 ± 49.67
Data are presented as mean values ± standard deviation of three independent replicates.
3.2. GP Restores Motor Performance after Treatment with LPS
In order to evaluate the effects on the motor performance of animals pre-treated with
GP and subjected to an inflammatory stimulus (LPS), the pole test and rotarod test were
performed following the experimental design shown in Figure 2.
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3.2.1. Pole Test
The pole test (Figure 4) measures the motor coordination of the animal. The mouse
is placed with its head facing upwards on a vertical pole immersed in the animal’s cage.
Initially, the operator measures the time taken for the animal to change direction and return
to its cage in basal conditions (without treatment) and establishes an average time. On the
day of the experiment, the operator measures the time taken for the animal to return to
its cage (Figure 4A) and establishes a “score” with respect to the basal time (Figure 4B).
High “score” values correspond to performances equal to or higher than those observed
in baseline.
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Figure 4. Motor coordination test: pole test. (A) Motor performance measured as total seconds
taken by the mouse to return to its cage; (B) motor performance measured as score. The score is the
algebraic sum of the values given to the time taken by the mouse to rotate on itself, to descend to the
upper half, to descend to the l wer half and to complete th total length of t e pol . If the mouse
compl tes every single step within 4 s, 3 point are awarded, within 8 s 2 poi ts are awarded and over
8 s 1 point is awarded. Data are shown as the me n ± SEM, nd ordin ry one-way ANOVA followed
by Dunnett’s multiple comparisons test was used for statistical significance; * p < 0.005 vs. VH;
# p < 0.005 vs. LPS.
Animals treated with LPS show significantly lower performance in motor coordi-
nation in the pole test than animals receiving vehicle only (p < 0.05). On the contrary,
animals pre-treated with GP and subsequently receiving LPS do not show altered per-
formance compared to the control group (VH) (Figure 4). The effects on motor perfor-
mance after different LPS treatments have been abundantly reported and discussed in the
literature [5,27,62–64]. LPS at both the cerebral and peripheral levels trigger an inflam-
matory response that alters motor skills [27,62]. Indeed, the peripheral administration of
LPS can trigger an alteration in the coordination of the motor response in the brain [62].
Likewise, the pole test was previously used to assess motor disorders associated with basal
ganglia in mice [34]. The coordination of movement is one of the main functions of the
basal ganglia of vertebrates, and neuro-inflammation compromises the local neuronal trans-
mission [62]. On the other hand, LPS often generates a local inflammatory response that
negatively affects motor coordination [65]. Indeed, LPS induces the release of inflammatory
cytokines (see below), which could contribute to the impaired motor coordination ob-
served in our experiments. Pre-treatment with GP appears to protect against motor deficits
induced by LPS treatment. The different components identified in the GP extract could
together contribute to improving the body’s response to the inflammatory stimulus [66].
3.2.2. Rotarod Test
Alterations in motor coordination were also observed in the rotarod test (Figure 5).
The rotarod test is one of the most commonly used tools to test motor coordination and
balance in mice. During the test, the mice must be able to walk on a rotating cylinder
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subjected to acceleration. The test measures the latency when mice fall from the rotating
cylinder. Different mouse models of neurological diseases such as Parkinson’s disorders,
amyotrophic lateral sclerosis, cerebellar ataxia, traumatic brain injury and stroke show
poor performance on the rotarod test [34]. Furthermore, even the animals treated with LPS
show strong difficulties in maintaining balance following the acceleration in the rotarod
test [34]. As observed in the pole test, pre-administration of GP protects against LPS-
induced motor coordination alteration in the rotarod test. The data graphically reported in
Figure 5 show that animals treated with LPS spend significantly less time than the control
group on the rotating cylinder. On the contrary, animals that received GP and LPS spent
significantly more time on the rotating cylinder compared to the LPS group. Indeed, more
significant motor coordination skills have been observed in animals pre-treated with GP
and subsequently with LPS than the LPS group. Since GP has no effect (ameliorative or
pejorative) on the motor coordination of animals that do not receive LPS, its action, in our
mouse model, would have a protective function against the inflammatory stimulus only.
As discussed above, Gynostemma genus contains certain metabolites that enhance muscle
proliferation by activating adenosine monophosphate-activated protein kinase (AMPK)
signalling pathways [67]. In particular, extracts of Gynostemma species restore the ability to
move in animal models with some motor alterations [67].




Figure 5. Rotarod test. Time, expressed in seconds, that the animal remains on the moving cylin-
der. Data are shown as the mean ± SEM, and ordinary one-way ANOVA followed by Dunnett’s 
multiple comparisons test was used for statistical significance; * p < 0.005 vs. VH; # p < 0.005 vs. 
LPS. 
3.3. GP Decreases the Inflammatory Cytokines after Treatment with LPS 
Inflammatory cytokines are molecular messengers released by the body in response 
to an inflammatory stimulus (bacteria, viruses and parasites) [68]. These signals act at the 
site of the inflammatory stimulus but can also induce a systemic response. In this work, 
the release of three cytokines involved in inflammation were measured: interleukin-1β 
(IL-1β), interleukin 6 (IL-6), and interleukin 10 (IL-10). The quantification was performed 
by means of an ELISA test (enzyme-linked immunosorbent assay) specific for the three 
cytokines. In Figure 6, it can be seen how the animals treated with LPS show a significant 
production of IL-1β and IL-6, two cytokines that promote inflammation. Indeed, it is 
known that the LPS stimulus causes an increase in the expression and release of IL-1β and 
IL-6, as reported by many authors [5,68–71]. The inflammatory response also depends on 
the LPS’ dosage. In our model, the use of 7.5 mg/kg of LPS triggered a considerable in-
flammatory response. At the same time, the release of IL-10 into the bloodstream of LPS-
treated mice also increased. IL-10 is considered an anti-inflammatory cytokine, and its 
expression correlates with acute inflammatory states as observed by Turner and col-
leagues [68]. Indeed, the increase in its expression determines, in the later stages of in-
flammation, a decrease in the release of inflammatory cytokines. Therefore, in our exper-
imental protocol, its increase in animals treated with LPS would indicate a compensatory 
action of the organism to counteract the inflammatory response. Data obtained demon-
strate that GP blocked the LPS-induced cytokine response. Indeed, the animals pre-treated 
with GP and which subsequently received LPS did not show an increase in the production 
of IL-1β, IL-6 and IL-10 compared to the control group (VH). Therefore, GP appears to 
block the inflammatory response by acting on the cytokines. This action can be associated 
with the multiple components identified in GP extract such as saponins, polyphenols and 
phytosterols. Indeed, many authors have reported the contribution of molecules belong-
ing to these three classes in reducing inflammatory cytokines [22,23,37,38,48,56,60,67,72]. 
Furthermore, we hypothesize that the anti-inflammatory action of GP can be attributed to 
the ability of the entire phytocomplex to block the effects of LPS, as already observed in 
many other plant species [67,72–74]. 
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Data are shown as the mean ± SEM, and ordinary one-way ANOVA followed by Dunnett’s multiple
comparisons test was used for statistical significance; * p < 0.005 vs. VH; # p < 0.005 vs. LPS.
3.3. GP Decreases the Inflammatory Cytokines after Treatment with LPS
Inflammatory cytokines are molecular messengers released by the body in response to
an inflammatory stimulus (bacteria, viruses and parasites) [68]. These signals act at the site
of the inflammatory stimulus but can also induce a systemic response. In this work, the
release of three cytokines involved in inflammation were measured: interleukin-1β (IL-1β),
interleukin 6 (IL-6), and interleukin 10 (IL-10). The quantification was performed by means
of an ELISA test (enzyme-linked immunosorbent assay) specific for the three cytokines. In
Figure 6, it can be seen how the animals treated with LPS show a significant production of
IL-1β and IL-6, two cytokines that promote inflammation. Indeed, it is known that the LPS
stimulus causes an increase in the expression and release of IL-1β and IL-6, as reported by
many authors [5,68–71]. The inflammatory response also depends on the LPS’ dosage. In
our model, the use of 7.5 mg/kg of LPS triggered a considerable inflammatory response.
At the same time, the release of IL-10 into the bloodstream of LPS-treated mice also
increased. IL-10 is considered an anti-inflammatory cytokine, and its expression correlates
with acute inflammatory states as observed by Turner and colleagues [68]. Indeed, the
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increase in its expression determines, in the later stages of inflammation, a decrease in the
release of inflammatory cytokines. Therefore, in our experimental protocol, its increase
in animals treated with LPS would indicate a compensatory action of the organism to
counteract the inflammatory response. Data obtained demonstrate that GP blocked the
LPS-induced cytokine response. Indeed, the animals pre-treated with GP and which
subsequently received LPS did not show an increase in the production of IL-1β, IL-6 and IL-
10 compared to the control group (VH). Therefore, GP appears to block the inflammatory
response by acting on the cytokines. This action can be associated with the multiple
components identified in GP extract such as saponins, polyphenols and phytosterols.
Indeed, many authors have reported the contribution of molecules belonging to these three
classes in reducing inflammatory cytokines [22,23,37,38,48,56,60,67,72]. Furthermore, we
hypothesize that the anti-inflammatory action of GP can be attributed to the ability of the
entire phytocomplex to block the effects of LPS, as already observed in many other plant
species [67,72–74].




Figure 6. Quantification of interleukin 1β (A), interleukin 6 (B) and interleukin 10 (C) from mice 
serum. Data are shown as the mean ± SEM, and ordinary one-way ANOVA followed by Dunnett’s 
multiple comparisons test was used for statistical significance; * p < 0.005 vs. VH; # p < 0.005 vs. 
LPS. 
4. Conclusions 
The data collected in this work highlighted the ability of GP to prevent both motor 
alterations and the inflammatory response in LPS-treated mice. LPS is found in the outer 
cell wall of Gram-negative bacteria and triggers the inflammatory response by binding to 
specific receptors located in monocytes, dendritic cells, macrophages and B cells, promot-
ing the secretion of pro-inflammatory cytokines, nitric oxide and eicosanoids [68]. This 
inflammatory reaction can also interfere with motor coordination. Indeed, some nerve cir-
cuits are responsible for the central motor coordination that transmits the signalling to the 
peripheral muscles [62]. The inflammatory reaction triggered by LPS can alter motor co-
ordination both in the brain and in the muscles [5,27,62]. Our results confirmed the in-
flammatory response and motor alterations in LPS-treated animals. In addition, animals 
pre-treated with GP and subsequently with LPS did not show alterations in inflammatory 
signalling and motor coordination. Our data suggested that the protective action might 
derive from the different molecules present in GP. This extract allows the exploitation of 
the therapeutic effects of all the components of the GP phytocomplex, such as saponins, 
polyphenols and phytosterols, identified in this work. In this regard, plant extracts 
Figure 6. Quantification of interleukin 1β (A), interleukin 6 (B) and interleukin 10 (C) from mice
serum. Data are shown as the mean ± SEM, and ordinary one-way ANOVA followed by Dunnett’s
multiple comparisons test was used for statistical significance; * p < 0.005 vs. VH; # p < 0.005 vs. LPS.
4. Conclusions
The data collected in this work highlighted the ability of GP to prevent both motor
alterations and the inflammatory response in LPS-treated mice. LPS is found in the outer
cell wall of Gram-negative bacteria and triggers the inflammatory response by binding to
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specific receptors located in monocytes, dendritic cells, macrophages and B cells, promoting
the secretion of pro-inflammatory cytokines, nitric oxide and eicosanoids [68]. This inflam-
matory reaction can also interfere with motor coordination. Indeed, some nerve circuits are
responsible for the central motor coordination that transmits the signalling to the peripheral
muscles [62]. The inflammatory reaction triggered by LPS can alter motor coordination both
in the brain and in the muscles [5,27,62]. Our results confirmed the inflammatory response
and motor alterations in LPS-treated animals. In addition, animals pre-treated with GP
and subsequently with LPS did not show alterations in inflammatory signalling and motor
coordination. Our data suggested that the protective action might derive from the different
molecules present in GP. This extract allows the exploitation of the therapeutic effects of all
the components of the GP phytocomplex, such as saponins, polyphenols and phytosterols,
identified in this work. In this regard, plant extracts showed remarkable anti-inflammatory
properties thanks to the presence of multiple molecules [66,75]. At the same time, other
authors highlighted the anti-inflammatory actions of single molecules purified from plant
extracts [5,36,38]. Further studies will be needed to evaluate whether the phytocomplex
of GP shows a greater anti-inflammatory power than any single molecule present in the
same phytocomplex. In addition, ecological aspects of GP (soil nutrients, abiotic and biotic
stress, intensity of light radiation, etc.) that can affect the content of secondary metabolites
will have to be considered.
In conclusion, GP showed a protective effect against the inflammatory stimulation
generated by the LPS. These data strengthen the therapeutic value of GP with important
applications both in the human and veterinary field.
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